These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34396551)

  • 21. Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity.
    Owen DR; Wood DM; Archer JR; Dargan PI
    Drug Alcohol Rev; 2016 Sep; 35(5):591-6. PubMed ID: 26693960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenibut dependence.
    Samokhvalov AV; Paton-Gay CL; Balchand K; Rehm J
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23391959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. U-90042, a sedative/hypnotic compound that interacts differentially with the GABAA receptor subtypes.
    Tang AH; Smith MW; Carter DB; Im WB; VonVoigtlander PF
    J Pharmacol Exp Ther; 1995 Nov; 275(2):761-7. PubMed ID: 7473164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The gamma-hydroxybutyrate withdrawal syndrome.
    Tarabar AF; Nelson LS
    Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamma hydroxybutyric acid (GHB) intoxication.
    Mason PE; Kerns WP
    Acad Emerg Med; 2002 Jul; 9(7):730-9. PubMed ID: 12093716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Repeated Administration of ɣ-Valerolactone (GVL) and GHB in the Mouse: Neuroadaptive Changes of the GHB and GABAergic System.
    Frisoni P; Corli G; Bilel S; Tirri M; Gasparini LC; Alfieri L; Neri M; De-Giorgio F; Marti M
    Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenibut (β-Phenyl-γ-Aminobutyric Acid): an Easily Obtainable "Dietary Supplement" With Propensities for Physical Dependence and Addiction.
    Jouney EA
    Curr Psychiatry Rep; 2019 Mar; 21(4):23. PubMed ID: 30852710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid.
    Carai MA; Colombo G; Brunetti G; Melis S; Serra S; Vacca G; Mastinu S; Pistuddi AM; Solinas C; Cignarella G; Minardi G; Gessa GL
    Eur J Pharmacol; 2001 Oct; 428(3):315-21. PubMed ID: 11689189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The activity of zolpidem and other hypnotics within the gamma-aminobutyric acid (GABAA) receptor supramolecular complex, as determined by 35S-t-butylbicyclophosphorothionate (35S-TBPS) binding to rat cerebral cortex membranes.
    Lloyd GK; Danielou G; Thuret F
    J Pharmacol Exp Ther; 1990 Nov; 255(2):690-6. PubMed ID: 2173755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of zolpidem treatment and withdrawal on the in vitro expression of recombinant alpha1beta2gamma2s GABA(A) receptors expressed in HEK 293 cells.
    Vlainić J; Jembrek MJ; Strac DS; Pericić D
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Sep; 382(3):201-12. PubMed ID: 20652804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxidrome of an Easily Obtainable Nootropic: A Case Report of Phenibut Intoxication and Withdrawal Delirium.
    Martin R; Buffenstein I; Cho D; Kiyokawa M
    J Clin Psychopharmacol; 2023 Nov-Dec 01; 43(6):507-510. PubMed ID: 37930202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. gamma-aminobutyric acidA receptor regulation: heterologous uncoupling of modulatory site interactions induced by chronic steroid, barbiturate, benzodiazepine, or GABA treatment in culture.
    Friedman LK; Gibbs TT; Farb DH
    Brain Res; 1996 Jan; 707(1):100-9. PubMed ID: 8866718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenibut: A drug with one too many "buts".
    Gurley BJ; Koturbash I
    Basic Clin Pharmacol Toxicol; 2024 Oct; 135(4):409-416. PubMed ID: 39197876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenibut: Review and Pharmacologic Approaches to Treating Withdrawal.
    Penzak SR; Bulloch M
    J Clin Pharmacol; 2024 Jun; 64(6):652-671. PubMed ID: 38339875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective changes in sensitivity to benzodiazepines, and not other positive GABA(A) modulators, in rats receiving flunitrazepam chronically.
    Gerak LR
    Psychopharmacology (Berl); 2009 Jul; 204(4):667-77. PubMed ID: 19274455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentration-effect relationships for the drug of abuse gamma-hydroxybutyric acid.
    Felmlee MA; Roiko SA; Morse BL; Morris ME
    J Pharmacol Exp Ther; 2010 Jun; 333(3):764-71. PubMed ID: 20215411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzodiazepines and Related Sedatives.
    Peng L; Morford KL; Levander XA
    Med Clin North Am; 2022 Jan; 106(1):113-129. PubMed ID: 34823725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenibutan-an Illegal Food Supplement With Psychotropic Effects and Health Risks.
    Bonnet U; Scherbaum N; Schaper A; Soyka M
    Dtsch Arztebl Int; 2024 Apr; 121(7):222-227. PubMed ID: 38377332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Insomnia due to hypnotic abuse].
    Poluektov MG; Pchelina PV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):24-29. PubMed ID: 28300810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.